News and Events
Hatchtech $2.5m new funding for Phase II head lice trials
28/11/2008 | Press Releases
Hatchtech Pty Ltd has secured $2.5 million in further funding from the University of Melbourne Endowment Trust (advised by GBS Venture Partners) and from Uniseed. The investment will be used to progress its unique head lice treatment into Phase II safety/efficacy studies in humans.